Agenus Inc.
AGEN
|
$5.3
6.64%
6.23%
1.5M
|
Health Technology
(0.0% 1d) (796.1% 1m) (207.3% 1y) (0.0% 2d) (-21.1% 3d) (-23.5% 7d) (Infinity% volume)
Earnings Calendar: 2024-03-14
Market Cap: $ 2,220,276,376
http://www.agenusbio.com
Sec Filling | Patents | 328 employees
(US) Agenus, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes AGEN1884, AGEN2034, INCAGN1876, INCAGN1949, Prophage, AutoSynVax, PhosphoSynVax, and AS-21 Stimulon. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 1994 and is headquartered in Lexington, MA.
cancer infectious disease
add to watch list Paper trade email alert is off
Press-releases
SaponiQx and InvivoGen Announce Agreement for SaponiQx to Supply Cultured Plant Cell QS-21 Adjuvant
Published: 2024-04-17 (Crawled : 13:00) - biospace.com/
AGEN | $5.3 6.64% 6.23% 1.5M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
qs-21 cell for agreement
Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
AGEN | $5.3 6.64% 6.23% 1.5M
|
Health Technology
|
| O: 1842.45%
H: 0.0%
C: 0.0%
cancer
MiNK Reports Fourth Quarter and Year-End 2023 Results
Published: 2024-03-21 (Crawled : 11:00) - globenewswire.com
INKT | $0.898 3.02% 2.93% 40K
|
|
| O: 1.56%
H: 0.0%
C: -2.2%
AGEN | $5.3 6.64% 6.23% 1.5M
|
Health Technology
|
| O: -0.54%
H: 5.09%
C: 1.92%
results
Agenus Reports Fourth Quarter and Full Year 2023 Results
Published: 2024-03-14 (Crawled : 13:00) - biospace.com/
AGEN | $5.3 6.64% 6.23% 1.5M
|
Health Technology
|
| O: 1.73%
H: 0.0%
C: -10.49%
year results
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report
Published: 2024-02-29 (Crawled : 16:00) - biospace.com/
AGEN | $5.3 6.64% 6.23% 1.5M
|
Health Technology
|
| O: -2.02%
H: 5.48%
C: -8.97%
report year update financial
Agenus to Participate in Leerink Partners Global Biopharma Conference
Published: 2024-02-26 (Crawled : 16:00) - biospace.com/
AGEN | $5.3 6.64% 6.23% 1.5M
|
Health Technology
|
| O: -0.4%
H: 9.95%
C: 6.79%
conference biopharma global
Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular Design
Published: 2024-02-15 (Crawled : 12:00) - prnewswire.com
AGEN | $5.3 6.64% 6.23% 1.5M
|
Health Technology
|
| O: -7.32%
H: 0.0%
C: -23.98%
vaccine contract molecular
Agenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference
Published: 2024-01-31 (Crawled : 17:00) - biospace.com/
AGEN | $5.3 6.64% 6.23% 1.5M
|
Health Technology
|
| O: -0.54%
H: 14.27%
C: 5.89%
conference life sciences
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors Market to grow by USD 2.23 billion between 2023 and 2028, growth Driven by High target affinity and specificity of CTLA4 inhibitors - Technavio
Published: 2024-01-26 (Crawled : 02:00) - prnewswire.com
XLO | $1.16 -9.38% -10.34% 340K
|
Professional, Scientific, and T...
|
| O: 4.69%
H: 4.55%
C: -2.99%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 2.92%
H: 1.06%
C: -3.05%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -1.35%
H: 0.12%
C: -0.83%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.07%
H: 0.1%
C: -0.94%
AGEN | $5.3 6.64% 6.23% 1.5M
|
Health Technology
|
| O: 3.13%
H: 11.02%
C: 7.11%
protein growth market
Botensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer Population
Published: 2024-01-22 (Crawled : 13:30) - biospace.com/
AGEN | $5.3 6.64% 6.23% 1.5M
|
Health Technology
|
| O: 12.46%
H: 1.52%
C: -9.46%
biomarker cancer tumor response
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10